Total Payments
$3,372
2024 Payments
$1,339
Companies
26
Transactions
144
Medicare Patients
460
Medicare Billing
$44,890
Payment Breakdown by Category
Food & Beverage$3,348 (99.3%)
Education$23.87 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,348 | 143 | 99.3% |
| Education | $23.87 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,282 | 68 | $0 (2024) |
| Janssen Biotech, Inc. | $261.97 | 14 | $0 (2024) |
| Celgene Corporation | $252.51 | 11 | $0 (2024) |
| Olympus Corporation of the Americas | $186.95 | 2 | $0 (2019) |
| Mauna Kea Technologies, Inc. | $166.22 | 2 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $143.57 | 2 | $0 (2023) |
| PFIZER INC. | $137.47 | 7 | $0 (2024) |
| GENZYME CORPORATION | $118.38 | 5 | $0 (2024) |
| Ardelyx, Inc. | $95.68 | 4 | $0 (2024) |
| Boston Scientific Corporation | $95.28 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,339 | 73 | ABBVIE INC. ($575.26) |
| 2023 | $1,192 | 55 | ABBVIE INC. ($476.53) |
| 2022 | $405.83 | 6 | ABBVIE INC. ($216.66) |
| 2020 | $13.80 | 1 | AbbVie Inc. ($13.80) |
| 2019 | $237.83 | 7 | Boston Scientific Corporation ($95.28) |
| 2018 | $182.92 | 2 | Olympus Corporation of the Americas ($135.54) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 278 | 309 | $112,115 | $26,087 |
| 2022 | 7 | 168 | 181 | $70,499 | $17,247 |
| 2021 | 1 | 14 | 14 | $2,810 | $1,556 |
Total Patients
460
Total Services
504
Medicare Billing
$44,890
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 38 | 38 | $33,706 | $7,570 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 46 | 67 | $6,365 | $3,361 | 52.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 19 | 19 | $12,483 | $3,307 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 34 | 34 | $6,460 | $2,992 | 46.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $21,660 | $2,112 | 9.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 20 | $5,600 | $1,869 | 33.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $2,812 | $1,131 | 40.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $15,960 | $1,129 | 7.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 21 | 21 | $2,625 | $1,112 | 42.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 24 | 29 | $1,740 | $781.48 | 44.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $2,704 | $723.80 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 61 | 61 | $11,590 | $5,654 | 48.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 16 | $14,192 | $3,112 | 21.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $8,541 | $2,434 | 28.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $15,120 | $1,999 | 13.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $16,606 | $1,856 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 30 | $2,850 | $1,601 | 56.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 20 | $1,600 | $590.63 | 36.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $2,810 | $1,556 | 55.4% |
About Dr. Lauren Pointer, MD
Dr. Lauren Pointer, MD is a Gastroenterology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1609255231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Pointer, MD has received a total of $3,372 in payments from pharmaceutical and medical device companies, with $1,339 received in 2024. These payments were reported across 144 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,348).
As a Medicare-enrolled provider, Pointer has provided services to 460 Medicare beneficiaries, totaling 504 services with total Medicare billing of $44,890. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location New Orleans, LA
- Active Since 05/28/2015
- Last Updated 07/06/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1609255231
Products in Payments
- RINVOQ (Biological) $757.69
- SKYRIZI (Biological) $349.27
- EVIS EXERA (Device) $234.33
- ZEPOSIA (Drug) $196.07
- DUPIXENT (Biological) $184.83
- STELARA (Biological) $152.51
- TERLIVAZ (Drug) $143.57
- XELJANZ (Drug) $137.47
- TREMFYA (Drug) $109.46
- IBSRELA (Drug) $95.68
- SPYGLASS (Device) $95.28
- VOQUEZNA (Drug) $92.41
- GATTEX (Drug) $91.14
- HUMIRA (Biological) $61.25
- VIBERZI (Drug) $56.02
- IDACIO (Biological) $55.59
- GIMOTI (Drug) $46.29
- CREON (Drug) $42.38
- VEGZELMA (Biological) $30.76
- RESMETIROM (Drug) $24.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New Orleans
Shobha Joshi, M.d, M.D
Gastroenterology — Payments: $289,442
Gastroenterology $289,442
Shamita Shah, M.d, M.D
Gastroenterology — Payments: $214,599
Gastroenterology $214,599
Nisha Loganantharaj
Gastroenterology — Payments: $132,345
Gastroenterology $132,345
Janak Shah, M.d, M.D
Gastroenterology — Payments: $56,752
Gastroenterology $56,752
Dr. Stephen Landreneau, M.d, M.D
Gastroenterology — Payments: $38,992
Gastroenterology $38,992
Vivek Huilgol, Md, MD
Gastroenterology — Payments: $34,990
Gastroenterology $34,990